TRIS

Tris Pharma, Inc

Application Filed: 2020-03-06

Trademark Application Details

Status

630

Live/Pending

NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

Research	OneLook Acronym Finder
Serial Number	88824807
Registration Number	6392554
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Cathy A. Kodroff
Attorney Docket Number	TRIS

Timeline

2015-01-01	Date of First Use
2020-03-06	Application Filed
2020-03-10	Location: NEW APPLICATION PROCESSING
2020-03-10	Status: Live/Pending
2020-03-10	Transaction Date
2021-06-22	Trademark Registered

Trademark Applicants & Owners

Owner:	TRIS PHARMA, INC
Address	Suite D 2033 Route 130 Monmouth Junction NJ 08852
Legal Entity Type	Corporation
Legal Entity State	NJ

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

CATHY A. KODROFF
HOWSON & HOWSON, LLP
325 SENTRY PARKWAY EAST
FIVE SENTRY EAST, SUITE 160
BLUE BELL, PA 19422

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	44
U.S. Codes:	100,101

Type Code	Type
GS0051	Pharmaceutical preparations, including, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors; cholesterol lowering medications; pharmaceutical preparations that act on the central nervous system; neuromodulators; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain
GS0051	Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain

Type Code

Type

GS0051

Pharmaceutical preparations, including, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors; cholesterol lowering medications; pharmaceutical preparations that act on the central nervous system; neuromodulators; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain

GS0051

Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2020-03-10	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2020-03-12	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2020-05-27	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2020-06-03	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2020-06-03	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2020-06-03	6 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2020-11-24	7 TROA I:Incoming Correspondence
ASSIGNED TO LIE	2021-02-25	8 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE	2021-02-25	9 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2021-02-25	10 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2021-03-01	11 CNSA O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2021-03-17	12 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2021-04-06	13 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2021-04-06	14 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2021-06-22	15 R.PR A:Allowance for Publication

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
TRIS 88824807 not registered Live/Pending	TRIS PHARMA, INC 2020-03-06
TRIS 87073076 not registered Dead/Abandoned	Lehigh Liquors Inc. 2016-06-15
TRIS 86439277 5205302 Live/Registered	Jeremias, Leo 2014-10-30
TRIS 85290893 not registered Dead/Abandoned	Quotidian Group Inc. 2011-04-08
TRIS 74408701 1827898 Dead/Cancelled	Transitional Residency Independence Services, Inc. 1993-06-30
TRIS 74408569 1827897 Dead/Cancelled	Transitional Residency Independence Services, Inc. 1993-06-30
TRIS 74222487 1796639 Live/Registered	Tris Kabushiki Kaisha 1991-11-15
TRIS 73772479 not registered Dead/Abandoned	ANGUS CHEMICAL COMPANY 1989-01-03
TRIS 73503349 1374627 Live/Registered	ISCO, INC. 1984-10-11
TRIS 73294414 1189864 Dead/Cancelled	I C Precision Corp. 1981-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.